Related Experiment Video
Updated: Mar 12, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
Extracellular Vesicles in Chronic Obstructive Pulmonary Disease.
Tsukasa Kadota1,2, Yu Fujita3,4, Yusuke Yoshioka5
1Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan. tskadota@ncc.go.jp.
Extracellular vesicles (EVs) are key in chronic obstructive pulmonary disease (COPD) development. This review explores how EVs contribute to COPD pathogenesis and their potential as COPD biomarkers and therapeutics.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Biochemistry
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue with complex, not fully understood, pathogenesis.
- Extracellular vesicles (EVs) are crucial mediators of intercellular communication, carrying diverse biomolecules.
- Recent research highlights the significance of EVs in pulmonary diseases, including COPD.
Purpose of the Study:
- To review current findings on the role of extracellular vesicles in the pathogenesis of chronic obstructive pulmonary disease (COPD).
- To explore the potential of EVs as diagnostic biomarkers for COPD.
- To discuss the therapeutic applications of EVs in managing COPD.
Main Methods:
- Literature review of recent studies on extracellular vesicles and COPD.
- Analysis of EV composition (miRNAs, mRNAs, proteins) and their functional roles.
- Synthesis of evidence linking EV-mediated processes to COPD development and progression.
Main Results:
- EVs are implicated in various aspects of COPD pathogenesis, including inflammation and tissue remodeling.
- EVs can transfer disease-associated molecules between lung cells.
- Specific EV profiles may serve as indicators of COPD presence and severity.
Conclusions:
- Extracellular vesicles play a significant role in the development and progression of COPD.
- EVs show promise as non-invasive biomarkers for COPD diagnosis and monitoring.
- Targeting EV-mediated pathways presents a potential therapeutic strategy for COPD treatment.
More Related Videos
06:39Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
Published on: September 1, 2023
09:18Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique
Published on: November 9, 2018
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History